ADMA BIOLOGICS, INC. (ADMA) › Total LiabilitiesADMA BIOLOGICS, INC. (ADMA) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2011: $2.54M2012: $6.13M2013: $10.41M2014: $21.01M2015: $22.89M2016: $28.14M2017: $67.69M2018: $69.11M2019: $100.90M2020: $119.42M2021: $135.08M2022: $196.49M2023: $193.98M2024: $139.66M2025: $146.92M$146.92M2011Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$146.92M+5.2%2024$139.66M-28.0%2023$193.98M-1.3%2022$196.49M+45.5%2021$135.08M+13.1%2020$119.42M+18.4%2019$100.90M+46.0%2018$69.11M+2.1%2017$67.69M+140.5%2016$28.14M+22.9%2015$22.89M+8.9%2014$21.01M+101.9%2013$10.41M+69.7%2012$6.13M+141.4%2011$2.54M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share